Real-world use of carfilzomib in relapsed multiple myeloma patients with pre-existing cardiovascular comorbidities

Comparative effectiveness of lenalidomide, bortezomib, and their combinations for elderly myeloma patients

Synthesis, preclinical analysis, and first-inhuman phase I imaging of 89Zr-DFOdaratumumab for CD38 targeted imaging of myeloma

A phase 1b study of once-weekly KRd in patients with newly diagnosed multiple myeloma

Adding daratumumab to existing multiple myeloma regimen of lenalidomide, bortezomib and dexamethasone

D-VTd in transplant-eligible newly diagnosed MM: Subgroup analysis of high-risk patients in CASSIOPEIA

Real-world use of carfilzomib therapy among patients with existing cardiovascular medical history

Maintenance with weekly carfilzomib in elderly newly diagnosed multiple myeloma

Twice-weekly vs once-weekly Krd in early relapsed refractory multiple myeloma

HORIZON: Melflufen in high risk relapsed refractory multiple myeloma patients with extramedullary disease

Improved outcomes from quadruplet KCRD induction in newly diagnosed myeloma patients

Once-weekly carfilzomib combined with lenalidomide and dexamethasone for multiple myeloma

What is the role of autologous stem cell transplant in multiple myeloma?

First results of the GMMG-CONCEPT trial for multiple myeloma

Iberdomide in combination with dexamethasone for multiple myeloma

PLEIADES: Daratumumab combinations for multiple myeloma

Treatment options for high risk relapsed/refractory multiple myeloma

Ruxolitinib, lenalidomide and methylprednisolone for relapsed/refractory multiple myeloma

BCMA: A new biomarker for multiple myeloma

ICARIA: Isatuximab, pomalidomide and dexamethasone in relapsed/refractory multiple myeloma

BELLINI: Venetoclax or placebo with bortezomib and dexamethasone for relapsed/refractory multiple myeloma

Continuous treatment versus fixed duration therapy: Using real-world evidence to guide treatment paradigms for multiple myeloma

Transitioning from bortezomib to ixazomib in patients with multiple myeloma